Paradigm Biocapital Advisors as of March 31, 2023
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 25 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 9.2 | $97M | 350k | 278.03 | |
| Incyte Corporation (INCY) | 8.6 | $91M | 1.3M | 72.27 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 6.9 | $73M | 1.5M | 48.22 | |
| Argenx Se Sponsored Adr (ARGX) | 6.4 | $68M | 181k | 372.58 | |
| Seagen | 5.4 | $57M | 282k | 202.47 | |
| Immunocore Hldgs Ads (IMCR) | 5.3 | $56M | 1.1M | 49.44 | |
| Arcellx Common Stock (ACLX) | 5.1 | $54M | 1.8M | 30.81 | |
| Miragen Therapeutics (VRDN) | 5.0 | $53M | 2.1M | 25.44 | |
| Mirati Therapeutics | 4.9 | $52M | 1.4M | 37.18 | |
| Syndax Pharmaceuticals (SNDX) | 4.6 | $48M | 2.3M | 21.12 | |
| United Therapeutics Corporation (UTHR) | 4.5 | $48M | 212k | 223.96 | |
| Keros Therapeutics (KROS) | 3.8 | $40M | 931k | 42.70 | |
| Beigene Sponsored Adr (BGNE) | 3.8 | $40M | 184k | 215.53 | |
| Cerevel Therapeutics Hldng I (CERE) | 3.7 | $39M | 1.6M | 24.39 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.7 | $39M | 1.8M | 21.27 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.6 | $38M | 351k | 107.22 | |
| Vor Biopharma (VOR) | 3.3 | $35M | 6.5M | 5.38 | |
| Zai Lab Adr (ZLAB) | 2.5 | $26M | 781k | 33.26 | |
| Xenon Pharmaceuticals (XENE) | 2.2 | $23M | 651k | 35.79 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.8 | $19M | 962k | 20.08 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $18M | 1.1M | 16.06 | |
| Alpine Immune Sciences (ALPN) | 1.7 | $18M | 2.3M | 7.72 | |
| Theseus Pharmaceuticals | 1.3 | $13M | 1.5M | 8.88 | |
| Olema Pharmaceuticals (OLMA) | 0.8 | $8.3M | 2.4M | 3.47 | |
| Poseida Therapeutics I (PSTX) | 0.3 | $3.3M | 1.1M | 3.08 |
